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1875-9572/Copyright ª 2016, Taiwan
BY-NC-ND license (http://creativecomBackground: Hepatic osteodystrophy is a common complication in patients with chronic liver dis-
ease, however, bone mineral status in patients with biliary atresia has rarely been investigated.
Methods: Twenty-nine children with biliary atresia were enrolled in our study and their demo-
graphic data, bone mineral density (BMD) of lumbar spine and bilateral femoral neck, and
biochemical parameters were measured and analyzed.
Results: The majority of our patients had osteopenia or osteoporosis over at least one part of the
skeleton although none had jaundice. Instead of T helper 1 cell cytokine, interleukin (IL)-4 had a
significant negative correlation with BMD of the right femoral neck (bZ 0.251, pZ 0.027) and
left femoral neck (bZ 0.299, pZ 0.012) independently by multiple linear regression analysis.
Conclusion: We conclude that chronic inflammation with increased expression of IL-4 may be an
important factor for compromised bone health in patients with biliary atresia.
Copyrightª 2016, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
Biliary atresia is an infantile disorder of progressive
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mons.org/licenses/by-nc-nd/4.0intrahepatic bile ducts that leads to cirrhosis.1 The
pathogenesis of biliary atresia is thought to be an auto-
immune response against the biliary epithelial cells after
an unknown viral infection. The life expectancy of pa-
tients with biliary atresia has improved greatly due to
early surgical intervention by Kasai portoenterostomy and
subsequent liver transplantation.2,3 However, several
complications developed in some of these patients,
including osteopenia and osteoporosis, or so-called “he-
patic osteodystrophy.”4ning Bone Mineral Density in Patients with Biliary Atresia after a
/dx.doi.org/10.1016/j.pedneo.2016.01.007
y Elsevier Taiwan LLC. This is an open access article under the CC
/).
2 M.-H. Chen et al
+ MODELThe mechanisms of bone disease in biliary atresia are
not entirely understood. Chronic cholestasis, malabsorption
of vitamin D and calcium, malnutrition, and decreased
physical activity or sunlight exposure are possible factors
contributing to bone loss in these patients.5e7 However,
compromised bone health was still identified in patients
with biliary atresia even without these risk factors.8 Pre-
vious studies have shown that CD4þ activated T helper (Th)
cells, with different Th-cell cytokines playing an important
role in the pathogenesis of biliary atresia. These include
Th1 [interleukin (IL)-2, interferon gamma (IFN-g)], Th2 (IL-
4, IL-10), Th3 [transforming growth factor (TGF)-b1], and
Th17 (IL-17) cytokines.9e12 These cytokines could also in-
fluence bone health in patients with chronic inflammatory
disease according to previous reports.13e16
Optimizing peak bone mass is of undoubted importance
during childhood.6 Nevertheless, data exploring the rela-
tionship between cytokines and bone health in children
with biliary atresia are rare. In this article, we evaluated
the demographic data, biochemical parameters, the con-
centrations of circulating cytokines, and bone mineral
density (BMD) to analyze the determinants of bone health
in children with biliary atresia.2. Material and methods
2.1. Study population
Between August 2010 and August 2011, 29 biliary atresia
patients (10 boys and 19 girls, age range 5e18 years) were
recruited during routine follow up at our hospital. All
patients had undergone a Kasai operation with short-
duration (<6 months) steroid treatment following the sur-
gery, and had no other chronic diseases. None of the pa-
tients received liver transplantation during enrollment. No
fever or other acute illness was noted in any of our par-
ticipants during blood sampling.
The study was approved by the institutional ethics
committee of our hospital. All parents of children with
biliary atresia and of the healthy controls were informed
of the study’s objectives. Informed consent from partici-
pating patients and/or parents was obtained before
enrollment in the study, in accordance with the Helsinki
Declaration.
2.2. Laboratory methods
Plasma was separated by centrifuging blood samples
anticoagulated with EDTA at 3000g for 10 minutes. The
plasma was stored at 70C after an additional centrifu-
gation at 13,000g for 10 minutes to ensure no contami-
nation. We measured plasma IL-2, IL-4, IL-10, IL-17, IFN-g,
and TGF-b1 concentrations using a commercially available
enzyme-linked immunosorbent assay kit (R&D Systems,
Minneapolis, MN, USA). The concentrations were calcu-
lated from a standard curve according to the manufac-
turer’s protocol. Plasma total bilirubin, direct bilirubin,
aspartate aminotransferase (AST), alanine aminotrans-
ferase, gamma glutamyl transpeptidase, albumin, and
calcium levels of biliary atresia patients were measuredPlease cite this article in press as: Chen M-H, et al., Factors Determ
Successful Kasai Operation, Pediatrics and Neonatology (2016), http:/by the central laboratory using the Hitachi 7180 auto-
mated test system.
2.3. BMD measurements
BMD of biliary atresia patients was analyzed using dual
energy X-ray absorptiometry (GE Lunar Prodigy Advance)
over posterioreanterior lumbar spine (L1eL4) and bilateral
femur neck areas. Control data were provided in the soft-
ware of GE Lunar Prodigy Advance. BMD Z-scores in each
part were obtained from comparisons of BMD with age- and
ethnically-matched norms. Children were classified into
normal, osteopenic, and osteoporotic by World Health Or-
ganization guidelines. Osteoporosis was defined as
BMD  2.5 standard deviation (SD) below the average
values (Z score  2.5). Osteopenia was defined as
BMD < 2.5 SD but > 1 SD under the average values (2.5 < Z
score < 1.0). Normal BMD was defined as BMD  1 SD
under the average values (Z score  1.0). BMD was
expressed as g/cm2.
2.4. Statistical analyses
Results are expressed as mean  SD. Analyses were per-
formed using the statistical package for the social science
(SPSS version 15.1; SPSS Inc., Chicago, IL, USA). The inde-
pendent sample t test was employed for comparison of
demographic and clinical data between groups. We applied
the Pearson correlation test for correlation analysis and
multiple linear regression analyses to investigate any re-
lationships between BMD and other various independent
parameters. A p value < 0.05 was considered statistically
significant.3. Results
BMD of the patients measured using dual energy X-ray
absorptiometry is summarized in Table 1. The majority of
children with biliary atresia (20/29, 69%) were identified
to have osteopenia over at least one part of the skeleton
in this study. BMD Z-scores were within the osteopenic/
osteoporotic range in 6/1 (21/3%), 16/1 (55/3%), and 12/2
(41/7%) patients, respectively, over anterioreposterior
lumbar spine (L1eL4), left femoral neck, and right
femoral neck. Significant difference between genders was
only found over BMD of the lumbar spine (p Z 0.010) but
there was no difference between BMD Z-scores. The mean
age- and ethnically-matched BMD Z-scores over three
areas were all below average value, approaching the
osteopenic range over the bilateral femoral neck (0.53,
e0.97, and 0.90).
Comparison of demographic data, biochemical pa-
rameters, and plasma cytokine levels between osteo-
penic and nonosteopenic biliary atresia patients at the
weight-bearing skeleton is shown in Table 2. All patients
enrolled in the study were nonjaundiced. No significant
difference was seen regarding age distribution, sex ratio,
body height, body weight, biochemical parameters, or six
plasma cytokine levels measured between the two
groups.ining Bone Mineral Density in Patients with Biliary Atresia after a
/dx.doi.org/10.1016/j.pedneo.2016.01.007
Table 1 BMD of biliary atresia patients.
BMD Z-scores (n Z 29) Normal Osteopenia Osteoporosis Abnormal BMD Z-scores (%)
Lumbar spine (L1eL4) 22 6 1 24
Left femoral neck 12 16 1 59
Right femoral neck 15 12 2 48
Total (n Z 29) Male (n Z 10) Female (n Z 19) p
Mean SD Mean SD Mean SD
Lumbar spine (L1eL4) BMD (g/cm2) 0.75 0.21 0.65 0.08 0.81 0.23 0.010
Lumbar spine (L1eL4) BMD Z-score 0.53 0.93 0.53 0.99 0.53 0.93 0.992
Left femoral neck BMD (g/cm2) 0.72 0.17 0.69 0.09 0.74 0.20 0.364
Left femoral neck BMD Z-score 0.97 0.91 0.88 0.42 1.03 1.09 0.598
Right femoral neck BMD (g/cm2) 0.73 0.17 0.71 0.07 0.74 0.20 0.583
Right femoral neck BMD Z-score 0.90 0.91 0.65 0.45 1.03 1.06 0.189
Normal: BMD Z-score  1.0; osteopenia: 2.5 < BMD Z-score < 1.0; osteoporosis: BMD Z-score  2.5.
BMD Z bone mineral density; SD Z standard deviation.
Table 2 Comparison of demographic data, biochemical parameters, and plasma cytokine levels between osteopenic and
nonosteopenic biliary atresia patients at the weight-bearing skeleton.
Parameters Osteopenia/Osteoporosis (n Z 20) Normal BMD (n Z 9) p
Mean SD Mean SD
Age (y) 9.4 2.9 11.6 4.45 0.191
Male/female 7:13 3:6 0.934
Height (cm) 129.3 16.8 140.5 18.4 0.127
Weight (kg) 29.9 11.5 41.7 16.7 0.066
AST (U/L) * 43.8 26.5 44.2 25.9 0.972
ALT (U/L) y 48.5 49.7 44.6 40.7 0.821
Bil-T (mg/dL) z 0.56 0.31 0.61 0.27 0.644
Bil-D (mg/dL) x 0.18 0.09 0.17 0.08 0.787
g-GT (U/L) jj 59.7 74.1 76.0 74.0 0.090
Alb (g/dL) { 4.3 0.3 4.2 0.6 0.697
Ca (mg/dL) # 9.2 0.7 9.2 0.6 0.964
IFN-g(pg/mL) 12.4 9.7 13.7 13.4 0.786
TGF-b1 (pg/mL) 9210.2 8202.1 5098.1 2581.8 0.057
IL-2 (pg/mL) 74.0 12.7 82.6 43.6 0.556
IL-4 (pg/mL) 4.0 0.4 3.9 0.5 0.591
IL-10 (pg/mL) 25.6 60.9 24.0 35.2 0.931
IL-17 (pg/mL) 57.7 19.4 59.8 37.4 0.874
Normal range of biochemical parameters: * 8e38 U/L; y 10e50 U/L for males and 10e35 U/L for females; z 0.1e1.2 mg/dL; x 0e0.2 mg/
dL; jj 4e63 U/L; { 3.5e5.0 g/dL; # 8.4e10.2 mg/dL.
Alb Z albumin; ALT Z alanine aminotransferase; AST Z aspartate aminotransferase; Bil-D Z direct bilirubin; Bil-T Z total bilirubin;
BMDZ bone mineral density; CaZ calcium; IFNZ interferon; ILZ interleukin; SDZ standard deviation; TGFZ transforming growth
factor.
Bone health in patients with biliary atresia 3
+ MODELPearson correlation analyses for BMD are shown in Table
3. BMD in patients with biliary atresia was highly correlated
(p < 0.001) with age and body mass index in all three parts.
There was also significant correlation (pZ 0.016 and 0.008,
respectively) between circulating IL-4 level and bilateral
femoral neck BMD.
We further performed multiple regression analyses with
BMD as the dependent variable (Table 4). Age was identified
to have a strongly positive correlation with lumbar and
bilateral femoral neck BMD. Circulating IL-4 level was
inversely correlated with left (bZ 0.299, pZ 0.012) and
right (bZ 0.251, pZ 0.027) femoral neck BMD (Figures 1Please cite this article in press as: Chen M-H, et al., Factors Determi
Successful Kasai Operation, Pediatrics and Neonatology (2016), http:/and 2). There was no correlation between BMD and other
parameters, including IFN-g level and body mass index.4. Discussion
In this study, we described the relationship between
different Th-cell cytokines and BMD in nonjaundiced pa-
tients with biliary atresia. It was proven that decreased
BMD was a common complication in patients with biliary
atresia,17,18 even when they were nonjaundiced.8 Our
findings indicate that circulating IL-4 level may be anning Bone Mineral Density in Patients with Biliary Atresia after a
/dx.doi.org/10.1016/j.pedneo.2016.01.007
Table 3 Pearson correlation analyses between parameters of biliary atresia patients.
Parameters Lumbar spine BMD Left femoral neck BMD Right femoral neck BMD
r p r p r p
Age 0.809 < 0.001 0.813 < 0.001 0.789 < 0.001
BMI 0.745 < 0.001 0.711 < 0.001 0.689 < 0.001
AST 0.165 0.392 0.096 0.622 0.163 0.397
ALT 0.011 0.955 0.222 0.248 0.313 0.098
Bil-T 0.144 0.457 0.278 0.144 0.317 0.094
Bil-D 0.036 0.852 0.152 0.431 0.159 0.410
g-GT 0.150 0.438 0.321 0.089 0.393 0.035
Alb 0.065 0.737 0.037 0.848 0.015 0.937
Ca 0.270 0.156 0.187 0.332 0.177 0.358
IFN-g 0.116 0.550 0.199 0.301 0.189 0.326
TGF-b1 0.058 0.766 0.269 0.158 0.270 0.157
IL-2 0.157 0.416 0.071 0.715 0.101 0.604
IL-4 0.318 0.093 0.444 0.016 0.482 0.008
IL-10 0.127 0.511 0.235 0.220 0.231 0.228
IL-17 0.087 0.652 0.079 0.682 0.061 0.752
Alb Z albumin; ALT Z alanine aminotransferase; AST Z aspartate aminotransferase; Bil-D Z direct bilirubin; Bil-T Z total bilirubin;
BMDZ bone mineral density; CaZ calcium; IFNZ interferon; ILZ interleukin; SDZ standard deviation; TGFZ transforming growth
factor.
Table 4 Multiple linear regression analyses with BMD as the dependent variable and other independent parameters of biliary
atresia patients.
Y Z Lumbar spine BMD Multiple linear regression: enter Multiple linear regression: stepwise
B Std. Err. b p B Std. Err. b p
Age 0.025 0.010 0.457 0.021 0.044 0.006 0.809 < 0.001
BMI 0.051 0.050 0.120 0.317
Female 0.022 0.011 0.352 0.051
IL-4 0.068 0.055 0.139 0.229
R 0.850 0.809
Adjusted R2 0.676 0.642
p for model < 0.001 < 0.001
Y Z Left femoral neck BMD Multiple linear regression: enter Multiple linear regression: stepwise
B Std. Err. b p B Std. Err. b p
Age 0.025 0.007 0.545 0.003 0.034 0.005 0.749 < 0.001
BMI 0.013 0.009 0.247 0.151
g-GT 8.3  105 2.6  104 0.035 0.753
IL-4 0.109 0.045 0.266 0.022 0.103 0.044 0.251 0.027
R 0.865 0.849
Adjusted R2 0.707 0.699
p for model < 0.001 < 0.001
Y Z Right femoral neck BMD Multiple linear regression: enter Multiple linear regression: stepwise
B Std. Err. b p B Std. Err. b p
Age 0.021 0.008 0.473 0.015 0.031 0.005 0.713 < 0.001
BMI 0.012 0.009 0.240 0.184
ALT 0.000 0.001 0.086 0.625
Bil-T 0.060 0.073 0.101 0.421
g-GT 0.000 0.000 0.159 0.344
IL-4 0.122 0.046 0.305 0.014 0.120 0.044 0.299 0.012
R 0.868 0.840
Adjusted R2 0.686 0.684
p for model < 0.001 < 0.001
bZ standardized coefficients; ALTZ alanine aminotransferase; BZ unstandardized coefficients; Bil-TZ total bilirubin; BMDZ bone
mineral density; g-GT Z gamma glutamyl transpeptidase; IL Z interleukin; Std. Err. Z standard error; Y Z dependent variable.
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Figure 1 Relationship between plasma (A) IFN-g and (B) IL-4
levels with left femoral neck BMD in the biliary atresia pa-
tients. Left femoral neck BMDs were inversely correlated with
plasma IL-4 levels (gZ 0.444, pZ 0.016) but not correlated
with plasma IFN-g levels (g Z 0.199, p Z 0.301).
BMD Z bone mineral density; IFN-g Z interferon gamma; IL-
4 Z interleukin-4.
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Figure 2 Relationship between plasma (A) IFN-g and (B) IL-4
levels with right femoral neck BMD in the biliary atresia pa-
tients. Right femoral neck BMDs were inversely correlated with
plasma IL-4 levels (gZ 0.482, pZ 0.008) but not correlated
with plasma IFN-g levels (g Z 0.189, p Z 0.326).
BMD Z bone mineral density; IFN-g Z interferon gamma; IL-
4 Z interleukin-4.
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atresia by multiple linear regression analysis.
Biliary atresia is one of the most common causes of
neonatal cholestasis. Patients with biliary atresia can ach-
ieve long-term survival in an era of successful Kasai por-
toenterostomy and liver transplantation.19 Preventing
complications, including hepatic osteodystrophy, has
become the focus of care in these patients. Previous studies
report that chronic cholestasis is a well-established risk
factor for bone disease.5,20 Other mechanisms including
malnutrition, malabsorption of minerals and fat-soluble
vitamins, medication, or poor mobility were also dis-
cussed.21 Due to the advancement in medical care, all pa-
tients in our study were free of jaundice, malnutrition, or
hypocalcemia according to our data. Plasma 25-
hydroxyvitamin D level was determined in three of our
patients and the results were all within the normal limit.
However, decreased BMD was still found in the majority of
our patients, especially over bilateral femoral neck areas.
The main pathogenesis of biliary atresia is believed to
be a chronic inflammation caused by an uncontrollable
autoimmune response. According to previous studies,
various cytokines released by CD4þ Th cells mayPlease cite this article in press as: Chen M-H, et al., Factors Determi
Successful Kasai Operation, Pediatrics and Neonatology (2016), http:/contribute to biliary atresia disease presentation and
progression.11,12 We can divide CD4þ Th cells into four
main subsets, including Th1, Th2, Th3, and Th17 cells.22
Th1 cells activate macrophages by IFN-g and IL-2, while
Th2 cells are responsible for humoral immune response by
IL-4 and IL-10. Th3 cells produce immune modulating and
suppressing cytokines such as TGF-b1. Th17 cells, a new
effector CD4þ T cell lineage, were recently recognized.
IL-17 is secreted by Th17 cells to recruit Th1 cells to the
site of inflammation.
In a report by Narayanaswamy et al,23 21 patients with
biliary atresia showed a marked increase in the levels of
Th1 (IFN-g and IL-2) and Th2 (IL-4) cytokines 6 months after
the Kasai operation, compared with at the time of opera-
tion. According to our previous report,12 increased IFN-g
levels were found in jaundice-free biliary atresia patients
with impaired liver function and portal hypertension. AST-
to-platelet ratio index (APRI) is a simple tool used to
assess the degree of liver fibrosis in children with biliary
atresia following Kasai surgery.24 IL-10 (Th2 cytokine) also
increased in biliary atresia patients with high APRI values.12
IFN-g and IL-10 are likely to be involved in progressive liver
injury in patients with biliary atresia. These resultsning Bone Mineral Density in Patients with Biliary Atresia after a
/dx.doi.org/10.1016/j.pedneo.2016.01.007
6 M.-H. Chen et al
+ MODELindicated the progressive immune response of these pa-
tients was nonpolarized to Th1 or Th2 immunity.
Bone disease is also found in other autoimmune or
chronic inflammatory disorders,25e27 therefore, it seems
reasonable to consider that various CD4þ Th cell secreting
cytokines may also cause osteopenia or osteoporosis in
patients with biliary atresia. An interesting finding of our
correlation analysis is that circulating IL-4 level, one of the
Th2 cytokines, was significantly negatively correlated with
BMD over bilateral femoral neck areas in patients with
biliary atresia after adjusting for confounding factors.
Although negative correlations between Th1, Th3, and Th17
cytokines and BMD were also observed, no significant dif-
ference was achieved. The mechanisms of liver injury and
bone disease in patients with biliary atresia may be
different.
Maintaining bone health is necessary for the balance
between bone formation and resorption. In 1993, Lewis
et al28 reported that osteoporosis was induced in mice by
the overproduction of IL-4 by the direction of the
lymphocyte-specific proximal promoter for the lck gene.
The results indicated that bone disease in lck-IL-4 mice
appeared to result from decreased bone formation by
marked atrophy of osteoblasts in lck-IL-4 bone tissue.
Osteoporosis is also a common complication in immunode-
ficiency patients with hyper-IgE syndrome exposed to
excess IL-4,29 therefore it is plausible that circulating IL-4
can contribute to bone loss in patients with biliary
atresia, although the precise mechanism is not known.
In conclusion, hepatic osteodystrophy is a common
complication in patients with biliary atresia even if they are
nonjaundiced. Optimizing peak bone mass is an important
issue during the childhood and adolescent periods for these
patients to prevent future complications in adulthood. Our
data also provided further evidence that chronic inflam-
mation with increased expression of IL-4 may be an inde-
pendent factor for osteopenia or osteoporosis over bilateral
femoral neck areas in patients with biliary atresia. Further
larger prospective studies are necessary to investigate the
mechanism of bone disease with various cytokines in order
to prevent or treat bone mineral deficits in children with
biliary atresia.
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